Switch theme
Sign up to access all valuation multiples
Teraplast SA is a Romania-based company engaged in the manufacture of plastic construction supplies and fixtures. The product portfolio of the company comprises three business lines: Installation and Design, Window profiles and Granules. The Company has two operating segments includes Installations (systems for sewage, water and gas) and Compounds.
1992
945
LTM Revenue $206M
LTM EBITDA $16.1M
$280M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Teraplast has a last 12-month revenue of $206M and a last 12-month EBITDA of $16.1M.
In the most recent fiscal year, Teraplast achieved revenue of $197M and an EBITDA of $12.1M.
Teraplast expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Teraplast valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $147M | $197M | XXX | XXX | XXX |
| Gross Profit | $49.3M | $54.3M | XXX | XXX | XXX |
| Gross Margin | 33% | 28% | XXX | XXX | XXX |
| EBITDA | $12.2M | $12.1M | XXX | XXX | XXX |
| EBITDA Margin | 8% | 6% | XXX | XXX | XXX |
| Net Profit | $3.4M | $0.4M | XXX | XXX | XXX |
| Net Margin | 2% | 0% | XXX | XXX | XXX |
| Net Debt | $39.5M | $48.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 15, 2025, Teraplast's stock price is RON 0 (or $0).
Teraplast has current market cap of RON 984M (or $216M), and EV of RON 1.3B (or $280M).
See Teraplast trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $280M | $216M | XXX | XXX | XXX | XXX | $0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 15, 2025, Teraplast has market cap of $216M and EV of $280M.
Teraplast's trades at 1.4x LTM EV/Revenue multiple, and 17.4x LTM EBITDA.
Analysts estimate Teraplast's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Teraplast and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $280M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 23.2x | XXX | XXX | XXX |
| P/E | -50.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -47.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTeraplast's NTM/LTM revenue growth is 18%
Teraplast's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged n/a for the same period.
Over next 12 months, Teraplast's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Teraplast's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Teraplast and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 34% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | -1% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 0% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 0% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Brickworks | XXX | XXX | XXX | XXX | XXX | XXX |
| Reece | XXX | XXX | XXX | XXX | XXX | XXX |
| Iktinos Hellas | XXX | XXX | XXX | XXX | XXX | XXX |
| Grupo Argos | XXX | XXX | XXX | XXX | XXX | XXX |
| ACC | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Teraplast acquired XXX companies to date.
Last acquisition by Teraplast was XXXXXXXX, XXXXX XXXXX XXXXXX . Teraplast acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Teraplast founded? | Teraplast was founded in 1992. |
| Where is Teraplast headquartered? | Teraplast is headquartered in Romania. |
| How many employees does Teraplast have? | As of today, Teraplast has 945 employees. |
| Who is the CEO of Teraplast? | Teraplast's CEO is Mr. Alexandru Stanean. |
| Is Teraplast publicy listed? | Yes, Teraplast is a public company listed on BSE. |
| What is the stock symbol of Teraplast? | Teraplast trades under TRP ticker. |
| When did Teraplast go public? | Teraplast went public in 2008. |
| Who are competitors of Teraplast? | Similar companies to Teraplast include e.g. Brickworks, Reece, Iktinos Hellas, Grupo Argos. |
| What is the current market cap of Teraplast? | Teraplast's current market cap is $216M |
| What is the current revenue of Teraplast? | Teraplast's last 12-month revenue is $206M. |
| What is the current EBITDA of Teraplast? | Teraplast's last 12-month EBITDA is $16.1M. |
| What is the current EV/Revenue multiple of Teraplast? | Current revenue multiple of Teraplast is 1.4x. |
| What is the current EV/EBITDA multiple of Teraplast? | Current EBITDA multiple of Teraplast is 17.4x. |
| What is the current revenue growth of Teraplast? | Teraplast revenue growth between 2023 and 2024 was 34%. |
| Is Teraplast profitable? | Yes, Teraplast is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
